Neuraminidase inhibitor-resistant influenza viruses may differ substantially in fitness and transmissibility. - Wikidata - wikimedia - TriplyDB

Neuraminidase inhibitor-resistant influenza viruses may differ substantially in fitness and transmissibility.

Neuraminidase inhibitor-resistant influenza viruses may differ substantially in fitness and transmissibility.

http://www.wikidata.org/entity/Q34077100

about

Resistance to anti-influenza drugs: adamantanes and neuraminidase inhibitors Neuraminidase inhibitors for preventing and treating influenza in children Current and future antiviral therapy of severe seasonal and avian influenza Lack of transmission of H5N1 avian-human reassortant influenza viruses in a ferret model Inefficient transmission of H5N1 influenza viruses in a ferret contact model Recent progress in structure-based anti-influenza drug design Animal models for influenza virus pathogenesis, transmission, and immunology Growth of an RNA virus in single cells reveals a broad fitness distribution Characterization of two distinct neuraminidases from avian-origin human-infecting H7N9 influenza viruses Binding of a natural anthocyanin inhibitor to influenza neuraminidase by mass spectrometry Predicting 'airborne' influenza viruses: (trans-) mission impossible?Exhaled aerosol transmission of pandemic and seasonal H1N1 influenza viruses in the ferret The M segment of the 2009 pandemic influenza virus confers increased neuraminidase activity, filamentous morphology, and efficient contact transmissibility to A/Puerto Rico/8/1934-based reassortant viruses Antiviral resistance and the control of pandemic influenza Neuraminidase inhibitor resistance in influenza: assessing the danger of its generation and spread Population-wide emergence of antiviral resistance during pandemic influenza Oseltamivir-resistant pandemic H1N1/2009 influenza virus possesses lower transmissibility and fitness in ferrets Resistance mutation R292K is induced in influenza A(H6N2) virus by exposure of infected mallards to low levels of oseltamivir Estimating the fitness advantage conferred by permissive neuraminidase mutations in recent oseltamivir-resistant A(H1N1)pdm09 influenza viruses Unique Determinants of Neuraminidase Inhibitor Resistance among N3, N7, and N9 Avian Influenza Viruses.Intervention strategies for an influenza pandemic taking into account secondary bacterial infections Drug resistance in influenza A virus: the epidemiology and management.Emergence of drug-resistant influenza virus: population dynamical considerations.Comparative dynamics and distribution of influenza drug resistance acquisition to protein m2 and neuraminidase inhibitors.Natural variation can significantly alter the sensitivity of influenza A (H5N1) viruses to oseltamivir.Emergence of a novel drug resistant H7N9 influenza virus: evidence based clinical potential of a natural IFN-α for infection control and treatment.Inhibition of influenza virus infection by a novel antiviral peptide that targets viral attachment to cells The threat of avian influenza H5N1: 'do we have the tools for the job'?The effect of population structure on the emergence of drug resistance during influenza pandemics.Neuraminidase inhibitor-resistant recombinant A/Vietnam/1203/04 (H5N1) influenza viruses retain their replication efficiency and pathogenicity in vitro and in vivo.The role of oseltamivir in the treatment and prevention of influenza in children.Oseltamivir-resistant influenza A viruses are transmitted efficiently among guinea pigs by direct contact but not by aerosol.Antiviral resistance and the control of pandemic influenza: the roles of stochasticity, evolution and model details.Meeting report: risk assessment of tamiflu use under pandemic conditions.Antiviral resistance during pandemic influenza: implications for stockpiling and drug use.Recombinant influenza virus with a pandemic H2N2 polymerase complex has a higher adaptive potential than one with seasonal H2N2 polymerase complex.Oseltamivir-resistant influenza A pandemic (H1N1) 2009 virus, Hong Kong, China.Influenza A virus transmission: contributing factors and clinical implications.Neuraminidase inhibitor sensitivity and receptor-binding specificity of Cambodian clade 1 highly pathogenic H5N1 influenza virus Effect of receptor binding domain mutations on receptor binding and transmissibility of avian influenza H5N1 viruses

P2860

Q22305941-17BFE723-4C83-4E65-96B4-F8DE56D34737 Q24243136-439775CE-6F86-42F2-BE1F-B19579EDD7AE Q24656164-A961B787-A257-45CB-BE42-1E8318D77ACB Q24670511-48D00EB5-DD6A-42D0-945D-561B0218F128 Q24684249-8069291C-42B8-4D15-B8F6-803DFBF3E4C2 Q26863710-33118AA8-055E-4660-95A3-E3A285C3410E Q27024582-8172ACA3-E26E-4444-8102-3483706F12D6 Q27488296-66AD4B44-FBD2-4080-A76A-DE881006DA09 Q27680477-B41485E7-0330-49D5-842D-2A5EE4B1B801 Q28292279-5B9B7386-25FE-4E7A-B9D8-82C5C5028D52 Q28382815-9B8B6833-677F-4293-874D-E19981EA4E2C Q28382996-8063BA9F-F257-4766-9355-98594F808820 Q28384333-4E0C9A65-3C20-4F47-97AE-14221F9A0206 Q28469119-013CE478-7C09-47F3-A88F-0773B0DF75F6 Q28471814-99686E44-3F65-4578-B068-33D8341C01DE Q28472381-ECB57DEB-53B5-4E8E-9974-C3CD63D7C0A4 Q28474960-04988D16-8035-40BF-AC28-D76BFAA42CCA Q28535274-A40C42A1-F627-4831-BCFC-778E6CD3031F Q28541953-EFF8F474-D491-4418-A0B6-71406E0FA20E Q30202859-C2833F1E-1C0D-4CAD-ACA4-FBD805311723 Q30227297-81201227-7648-4166-A90A-C102537F6986 Q30234600-D296DC37-19F0-4DCF-96D7-F65E18576E60 Q30353989-3C4E867B-CD6E-4D04-9ECF-5F8069E7E2A6 Q30355434-AED33376-19B3-44EA-8E03-24DBD153668C Q30356532-E5CA5A93-AC33-4094-BA26-B3B3B21476A5 Q30357014-0073AC71-DBB4-442D-9B00-A57B38243BD2 Q30357092-4ECA96C2-CC44-401E-83FB-19CEA37E0890 Q30362060-9525CA42-342C-4295-B679-9DCEE247F952 Q30362753-B2146931-2D59-4AB3-8F84-157205A13E68 Q30364619-32EF92AA-63E0-43AC-8E21-1723EE8262AA Q30364977-46773CD4-8BA7-4BF5-A21A-EDAD950D0708 Q30371242-1F704553-68F1-4953-85B1-DC7FB0B12366 Q30372938-397DC167-0356-46C8-A582-2EF92A721B98 Q30373734-1B0B76E2-C195-4C2F-A20C-D594603531A4 Q30374475-B4CE3E8F-049E-4081-9E30-24EF5EE67F95 Q30382876-C817BA15-7CA9-4AB0-BCC3-17C2794ABF79 Q30383194-AB061B00-3A06-4819-B1BB-BBE28C161D49 Q30397203-97B6A695-E9D8-4F71-830B-4D819EBAD458 Q30400058-4DEA65EF-6E35-45BC-B40B-FE59F3D30085 Q30400680-11F41CB4-CEF4-44CB-BA3B-104C2FA8DDFD

P2860

Neuraminidase inhibitor-resistant influenza viruses may differ substantially in fitness and transmissibility.

http://www.wikidata.org/entity/Q34077100

description

2005 nî lūn-bûn

@nan

2005 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Neuraminidase inhibitor-resist ...... fitness and transmissibility.

@ast

Neuraminidase inhibitor-resist ...... fitness and transmissibility.

@en

Neuraminidase inhibitor-resist ...... fitness and transmissibility.

@nl

type

label

Neuraminidase inhibitor-resist ...... fitness and transmissibility.

@ast

Neuraminidase inhibitor-resist ...... fitness and transmissibility.

@en

Neuraminidase inhibitor-resist ...... fitness and transmissibility.

@nl

prefLabel

Neuraminidase inhibitor-resist ...... fitness and transmissibility.

@ast

Neuraminidase inhibitor-resist ...... fitness and transmissibility.

@en

Neuraminidase inhibitor-resist ...... fitness and transmissibility.

@nl

P1433

Q34077100-EF125D37-9255-422B-BC7D-3960863DFE1A

P1476

Q34077100-60D06892-3511-4193-9BB8-CDC16CB5A1AB

P2093

Q34077100-20F1C0CF-5C0A-48CA-8D18-6260EAE9F9EB

Q34077100-4B3815BF-C6C7-4AD6-9E72-D5E9CB384FFB

Q34077100-71D517E4-C4F9-4CA2-B276-5F9EA257FED3

Q34077100-858EC4BF-A0E1-4813-81AE-3DC9905BB37F

P2860

Q34077100-008B42D0-316D-44C4-BE9A-B8ED2ACAF7B5

Q34077100-0843BBCA-0F0C-4FEF-8C74-3041B5AEE212

Q34077100-0FDC9098-5AD1-4D6F-8740-E8A955B660D8

Q34077100-0FDD74D0-AB45-4F78-948A-ABC7925CCF08

Q34077100-12F0E771-9D45-46E8-AD4E-462E41022D2C

Q34077100-17107127-98C7-4E38-BEE0-C975757AB593

Q34077100-17320ADF-A661-4F21-A607-0AFDAA5A1E74

Q34077100-186F603C-299A-4B7A-B81F-CBFA56DCE5A8

Q34077100-2440FE1D-FCC8-465B-A096-39008B4F5F6C

Q34077100-2BEA22E3-F37A-4B73-A537-45B24DE3B5CC

P304

Q34077100-9FB9C359-0F15-422A-9031-163166E5195A

P31

Q34077100-20CC8C69-5804-4BD7-9CF6-20ECB7AA236B

P356

Q34077100-3EAA8C31-2B9B-4DC4-9742-5F5200AF13B3

P407

Q34077100-8C113CC9-D055-4606-A8DB-ED2766A3F6DD

P433

Q34077100-EA5D84FB-0B95-4EB6-8ACE-FFC2F697033F

P478

Q34077100-AD941753-F3E6-4213-88BD-73C55279FAEE

P50

Q34077100-6A09B272-8E22-49D6-A2A1-2DC7D116D666

Q34077100-E50E096F-3948-437D-B630-6F0891B72C9B

Q34077100-F56C4AF8-4539-417B-854C-183DDAE2FE78

P577

Q34077100-9F3DADBA-6D65-4877-A52D-A41C2D07C98E

P5875

Q34077100-929DE383-6304-4548-BF54-A98AD72F7C8F

P698

Q34077100-BFB93543-3E2E-4E1F-9F5E-110232E1DFE8

P932

Q34077100-D346AC5B-857B-4FFF-9760-8900AB5850E7

P356

AAC.49.10.4075-4084.2005

P1433

Antimicrobial Agents and Chemotherapy

P1476

Neuraminidase inhibitor-resist ...... fitness and transmissibility.

@en

P2093

Erich Hoffmann

http://www.w3.org/2001/XMLSchema#string

Hui-Ling Yen

http://www.w3.org/2001/XMLSchema#string

Louise M Herlocher

http://www.w3.org/2001/XMLSchema#string

Mikhail N Matrosovich

http://www.w3.org/2001/XMLSchema#string

P2860

The structure of the complex between influenza virus neuraminidase and sialic acid, the viral receptor

Comparison of the activities of zanamivir, oseltamivir, and RWJ-270201 against clinical isolates of influenza virus and neuraminidase inhibitor-resistant variants.

Characterization of human influenza virus variants selected in vitro in the presence of the neuraminidase inhibitor GS 4071.

A DNA transfection system for generation of influenza A virus from eight plasmids

Influenza virus neuraminidase inhibitors.

Detection of influenza virus resistance to neuraminidase inhibitors by an enzyme inhibition assay.

Antivirals for pandemic influenza.

Neuraminidase sequence analysis and susceptibilities of influenza virus clinical isolates to zanamivir and oseltamivir.

Overexpression of the alpha-2,6-sialyltransferase in MDCK cells increases influenza virus sensitivity to neuraminidase inhibitors

Emergence and apparent transmission of rimantadine-resistant influenza A virus in families.

P304

4075-4084

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.49.10.4075-4084.2005

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

49

http://www.w3.org/2001/XMLSchema#string

P50

Robert G. Webster

Elena A Govorkova

P577

2005-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7575601

http://www.w3.org/2001/XMLSchema#string

P698

16189083

http://www.w3.org/2001/XMLSchema#string

P932

1251536

http://www.w3.org/2001/XMLSchema#string